Search
Alvotech SA
ALVOAdd to Watchlist
5.810USD
-0.030-0.51%
Close 09-23 16:00（ET）
2.27BMarket Cap
60.40P/E TTM
Alvotech SA (ALVO) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Alvotech SA in the past month.
Buy
1 Strong Buy
2 Buy
1 Hold
1 Sell
0 Strong Sell
Target Price
7.250USD+24.14%
ALVO Analyst Recommendation Trends
In the current month, ALVO has received 2 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. ALVO average Analyst price target in the last month is 7.250.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
1
1
1
2
2
3
3
3
3
3
3
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
0
5
5
6
6
6
6
6
5
ALVO Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, ALVO EPS is projected to reach -0.047 in FY2026Q3, following reported EPS of -0.238 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.04
0.02
-0.03
-0.05
0.18
Actual
-0.38
0.00
-0.24
--
--
Surprise
-737.98%
-80.20%
-779.78%
--
--
FAQs
What is Alvotech SA's expected revenue for the next quarter?
Alvotech SA's expected revenue is 128.56M.
What is Alvotech SA's price target?
Analysts forecast that Alvotech SA's price target is USD 7.25, with the highest forecast at USD 9.50 and the lowest forecast at USD 4.00.
What is the analyst rating for Alvotech SA?
Based on the ratings of Alvotech SA's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.